Moleculin Biotech
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell MBRX and other ETFs, options, and stocks.About MBRX
Moleculin Biotech, Inc. is a clinical stage pharmaceutical company. It engages in the business of growing a pipeline including phase 2 clinical programs for hard-to-treat cancers and viruses.
MBRX Key Statistics
Stock Snapshot
The current Moleculin Biotech(MBRX) stock price is $4.09, with a market capitalization of 8.49M. The stock trades at a price-to-earnings (P/E) ratio of -0.07.
On 2025-12-17, Moleculin Biotech(MBRX) stock traded between a low of $3.63 and a high of $6.66. Shares are currently priced at $4.09, which is +12.7% above the low and -38.6% below the high.
The Moleculin Biotech(MBRX)'s current trading volume is 5.96M, compared to an average daily volume of 1.07M.
In the last year, Moleculin Biotech(MBRX) shares hit a 52-week high of $91.25 and a 52-week low of $3.63.
In the last year, Moleculin Biotech(MBRX) shares hit a 52-week high of $91.25 and a 52-week low of $3.63.
MBRX News
Claim 50% Off TipRanks Premium and Invest with Confidence Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper...
In a report released today, Sara Nik from H.C. Wainwright reiterated a Buy rating on Moleculin Biotech, with a price target of $22.00. Claim 50% Off TipRanks Pr...